Entrada Therapeutics Earnings
NASDAQ: TRDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.68+0.145 (+2.62%)
Market open · Delayed 15 min · as of Oct 9, 1:01 PM ET
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.98
Entrada Therapeutics earnings summary
Entrada Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.98.
Summary generated from market data by MetaCap's automated system. Methodology